↓ Skip to main content

Dove Medical Press

An evidence-based review of ixazomib citrate and its potential in the treatment of newly diagnosed multiple myeloma

Overview of attention for article published in OncoTargets and therapy, September 2014
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (54th percentile)
  • Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

patent
19 patents

Citations

dimensions_citation
44 Dimensions

Readers on

mendeley
78 Mendeley
Title
An evidence-based review of ixazomib citrate and its potential in the treatment of newly diagnosed multiple myeloma
Published in
OncoTargets and therapy, September 2014
DOI 10.2147/ott.s49187
Pubmed ID
Authors

Massimo Offidani, Laura Corvatta, Patrizia Caraffa, Silvia Gentili, Laura Maracci, Pietro Leoni

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 78 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
United States 1 1%
Colombia 1 1%
Unknown 75 96%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 12 15%
Researcher 11 14%
Student > Master 11 14%
Other 8 10%
Student > Postgraduate 7 9%
Other 18 23%
Unknown 11 14%
Readers by discipline Count As %
Medicine and Dentistry 23 29%
Agricultural and Biological Sciences 14 18%
Biochemistry, Genetics and Molecular Biology 12 15%
Chemistry 6 8%
Pharmacology, Toxicology and Pharmaceutical Science 3 4%
Other 6 8%
Unknown 14 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 March 2024.
All research outputs
#8,534,528
of 25,373,627 outputs
Outputs from OncoTargets and therapy
#547
of 3,016 outputs
Outputs of similar age
#82,110
of 248,666 outputs
Outputs of similar age from OncoTargets and therapy
#4
of 28 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,016 research outputs from this source. They receive a mean Attention Score of 2.9. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 248,666 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.
We're also able to compare this research output to 28 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.